NCT05062070View on ClinicalTrials.gov

Safety and Efficacy of Topical TolaSure Targeting Aggregated Mutant Keratin in Severe Epidermolysis Bullosa Simplex

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 5, 2022

Primary Completion Date

June 22, 2023

Study Completion Date

June 22, 2023

Conditions
Epidermolysis Bullosa Simplex
Interventions
DRUG

TolaSure Topical Gel

TolaSure Topical Gel is applied once-daily for up to 10 weeks to designated Treatment Area and Suction Blister Area.

DRUG

Vehicle Topical Gel

TolaSure Vehicle Gel is applied once-daily for up to 10 weeks to designated Treatment Area and Suction Blister Area.

Trial Locations (1)

94063

Stanford University School of Medicine, Dermatology Department, Redwood City

All Listed Sponsors
lead

BioMendics, LLC

INDUSTRY